The Future Infrastructure of Psychedelic Medicine
A New Framework for Psychedelic Medicine, Clinical Training, and Global Mental Health Infrastructure
hollograf is building an integrated ecosystem for the future of psychedelic assisted healthcare. From clinician education and Authorised Prescriber pathways, to clinical infrastructure, research, patient access, and future treatment facilities, hollograf is designed to bridge the gap between emerging psychedelic therapies and real world healthcare implementation.
Our mission is simple: To help build safe, scalable, ethical, and clinically rigorous pathways for the next generation of mental health treatment.
What Is hollograf?
The Company for the Next Era of Mental Healthcare
hollograf is an integrated psychedelic medicine and mental health infrastructure group operating across education, clinical services, practitioner pathways, research, and future treatment facilities. Positioned as one of the emerging leaders in the Asia Pacific region, hollograf brings together clinician training, Authorised Prescriber support, virtual and physical clinic infrastructure, patient access systems, clinical research, and strategic media platforms under one unified ecosystem. Through divisions including the hollograf Institute, International College of Psychedelics (ICP), hollograf Clinics, hollograf Labs, and FRACT.co, the company is building scalable infrastructure for the future of regulated psychedelic assisted healthcare.
The company is structured to support the entire lifecycle of psychedelic assisted treatment and clinician participation:
Professional education
Practitioner readiness
Ethics and AP pathways
Clinical infrastructure
Patient onboarding
Research and evidence development
Media and public education
International expansion opportunities
The long term vision is to position hollograf as one of the first globally integrated psychedelic healthcare infrastructure companies operating across education, clinics, research, and regulated treatment environments.
The hollograf Ecosystem
Built Across Multiple Divisions
hollograf Institute
Professional training and practitioner readiness.
International College of Psychedelics (ICP)
Advanced psychedelic medicine education programs.
Authorised Prescriber Pathway
Structured AP preparation and ethics support for Australian psychiatrists.
hollograf Clinics
Virtual and physical psychedelic assisted therapy infrastructure.
hollograf Labs
Research, protocol development, data infrastructure, and clinical innovation.
FRACT.co
Clinical trial and research operations division.
Future International Facilities
Planned expansion into retreat based, mental health, and medical tourism environments in strategic jurisdictions such as Thailand.
Media & Strategic Partnerships
Close alignment with industry media and communications platforms including Psychedelics.media.
Copyright International College of Psychedelics 2025
All Rights Reserved hollograf Inc 2026
The Problem
Psychedelic Medicine Is Advancing Faster Than Infrastructure
Psychedelic assisted therapies are entering regulated clinical frameworks globally. However, healthcare systems remain severely underprepared.
Clinicians often face:
Limited professional training pathways
Unclear regulatory processes
Lack of operational infrastructure
Ethics committee complexity
Minimal mentorship opportunities
Administrative burden
Difficulty sourcing compliant treatment environments
Limited patient intake systems
Fragmented research ecosystems
At the same time, patients seeking legal, evidence informed treatment pathways continue to grow. hollograf exists to help close this gap.
hollograf Institute
Professional Education for Psychedelic Medicine
The hollograf Institute is focused on preparing healthcare professionals for emerging psychedelic assisted treatment models. The Institute combines scientific literacy, ethical frameworks, clinical readiness, operational understanding, and real world implementation pathways.
Programs are designed for:
Psychiatrists
Psychologists
Nurses
Therapists
Pharmacists
Allied health professionals
Researchers
Healthcare executives
Core Areas of Focus
Psychedelic assisted therapies
Clinical frameworks and treatment models
Risk management
Patient screening
Trauma informed care
Ethics and governance
Regulatory systems
Integration methodologies
Emerging clinical evidence
The objective is not simply education. The objective is practitioner readiness.
International College of Psychedelics (ICP)
Advanced Clinical Education Pathways
The International College of Psychedelics (ICP) operates as a flagship educational division within the hollograf ecosystem. ICP is designed to support healthcare professionals seeking advanced competency in psychedelic medicine and emerging mental health modalities.
Programs combine:
Structured coursework
Expert led discussions
Clinical frameworks
Case based learning
Evidence review
Operational implementation
Regulatory navigation
Flexible Learning Models
Full time pathways
Part time pathways
Online delivery
Hybrid workshops
Future in person intensives
Authorised Prescriber Pathway
Supporting Australian Psychiatrists Through the AP Process
Australia became one of the first countries in the world to formally permit authorised prescribing pathways for certain psychedelic compounds in psychiatry. However, the process remains operationally complex.
The hollograf Authorised Prescriber Pathway is designed to help eligible psychiatrists navigate:
01
AP application preparation
02
Ethics committee documentation
03
Governance frameworks
04
Operational readiness
05
Clinical protocols
06
Risk management structures
07
Treatment infrastructure considerations
A Structured Professional Support Pathway
The AP pathway is intended to reduce administrative friction and improve practitioner confidence during the application and implementation process. hollograf does not guarantee AP approval outcomes. Instead, the program is designed to support preparedness, compliance awareness, and operational capability.
Post Approval Clinical Infrastructure
Following AP approval and subject to individual treatment frameworks, practitioners may also be eligible to access optional hollograf clinical support services.
Treatment room access
Virtual clinic infrastructure
Patient onboarding systems
Administrative support
Therapy coordination
Operational logistics
Treatment environment access
Case by case implementation support
Support structures are individually assessed depending on practitioner requirements, treatment models, and jurisdictional considerations.
hollograf Clinics
Infrastructure for Psychedelic Assisted Care
hollograf Clinics are being developed as scalable treatment infrastructure environments supporting psychedelic assisted therapy delivery. The model includes both virtual and physical care systems.
Clinical Infrastructure Focus
Practitioner support
Patient intake systems
Screening pathways
Operational coordination
Treatment logistics
Therapy environment frameworks
Integration support systems
Future multidisciplinary collaboration
The long term objective is to help reduce barriers preventing qualified clinicians from participating in regulated psychedelic treatment models.
Patient Access & Recruitment
Helping Connect Eligible Patients With Emerging Treatment Pathways
A major challenge within psychedelic assisted care is the disconnect between patients seeking treatment and clinicians capable of providing regulated pathways.
hollograf aims to develop compliant patient access and onboarding systems designed to:
Improve treatment awareness
Streamline patient inquiry pathways
Support pre screening processes
Improve practitioner matching
Reduce administrative burden
Support continuity of care
All patient engagement systems are intended to operate within applicable regulatory and ethical frameworks.
hollograf Labs
Research, Innovation, and Clinical Data Infrastructure
hollograf Labs represents the innovation and research division of the broader ecosystem. The objective of hollograf Labs is to help contribute to the development of evidence based psychedelic medicine.
Through:
Protocol development
Data collection frameworks
Treatment outcome analysis
Digital infrastructure
Clinical innovation
Future intellectual property opportunities
Research partnerships
Emerging therapeutic models
As the psychedelic medicine industry matures, research quality and operational data will become increasingly important. hollograf Labs is designed to support this next phase.
Clinical Research Operations
FRACT is the dedicated research and clinical trial operations arm of the hollograf ecosystem. The platform is focused on helping facilitate structured, compliant, and operationally sound clinical research.
FRACT is designed to help facilitate:
Clinical trial coordination
Research partnerships
Participant recruitment
Data management
Protocol implementation
Site support infrastructure
Sponsor collaboration
Future Focus Areas
Psychedelic medicine trials
Novel therapeutics
Mental health innovation
Translational research
Real world evidence generation
FRACT is designed to sit at the intersection of emerging psychedelic therapies, clinical science, and operational execution.
Future International Expansion
Exploring Ethical Global Mental Health Infrastructure
hollograf is actively exploring future expansion opportunities beyond Australia. This includes evaluating jurisdictions that may support integrated mental health and psychedelic assisted treatment environments.
This includes evaluating jurisdictions that may support:
Integrated mental health facilities
Psychedelic assisted treatment environments
Medical tourism opportunities
Retreat style therapeutic infrastructure
International practitioner training
Research collaborations
Thailand is one potential jurisdiction under strategic evaluation due to its evolving healthcare, wellness, and alternative medicine sectors.
Any future expansion would prioritise:
Regulatory compliance
Clinical integrity
Ethical operations
Patient safety
Evidence informed care
All Rights Reserved hollograf Inc 2026
Media, Communications & Industry Positioning
Connected to the Broader Psychedelic Conversation
hollograf maintains close strategic alignment with media, communications, and industry education initiatives. This positioning ensures the company remains connected to the broader psychedelic medicine conversation — across clinical, regulatory, investor, and public audiences.
Strategic Media Alignment
hollograf works in close alignment with Psychedelics.media and other industry communications platforms to support public education, professional awareness, and responsible media coverage of psychedelic medicine.
Industry Positioning
By maintaining a presence across education, clinical infrastructure, research, and media, hollograf is positioned as a credible, multi-dimensional voice in the emerging psychedelic healthcare sector.
Credible to clinicians, regulators, and researchers
Accessible to patients and the public
Compelling to investors and strategic partners
All Rights Reserved hollograf Inc 2026
Patient Support & Stabilisation
A Smarter Support Pathway for Complex Patients
At Hollograf, we believe integrative medicine should be supported by responsible clinical oversight, behavioural care, and long-term patient monitoring.
As Australia's integrative health landscape continues to evolve, clinics and practitioners are increasingly supporting individuals with complex mental health histories, changing behavioural presentations, escalating treatment needs, and inconsistent outcomes. The Patient Support & Stabilisation Program was developed to help address that gap.
This is not a restrictive or punitive program. It is a patient-centred support service designed to help individuals build a healthier, more sustainable relationship with their treatment , improving safety, outcomes, and overall wellbeing.
Supporting Better Long-Term Outcomes
Our team works with individuals experiencing challenges related to:
- Escalating tolerance or changing treatment responses
- Anxiety, sleep, or mood instability
- Loss of treatment balance or effectiveness
- Overconsumption or problematic behavioural patterns
- Mental health concerns associated with lifestyle or treatment factors
- Poor routine, motivation, or behavioural regulation
- Difficulty maintaining healthy treatment habits
- Dependence-related behaviours or withdrawal concerns
Using structured assessments and behavioural screening tools, Hollograf helps individuals better understand how lifestyle, behavioural patterns, treatment routines, and mental health factors may be impacting daily functioning, cognition, sleep, and overall wellbeing.
From there, we develop personalised stabilisation and support plans that may include:
- Treatment and dosage reviews
- Behavioural health support
- Mental health screening and monitoring
- Harm minimisation education
- Structured reduction strategies where appropriate
- Sleep, routine, and lifestyle support
- Referral pathways into broader mental health services
Our goal is to help individuals regain balance, improve quality of life, and support healthier long-term treatment outcomes through evidence-informed, patient-centred care.
A Support Partner for Clinics & Practitioners
The Patient Support & Stabilisation Program provides an external support pathway for clinics and practitioners managing more complex patient presentations. Rather than leaving individuals without support, practitioners can refer patients into a structured behavioural and monitoring program focused on:
- Patient stabilisation
- Responsible treatment support
- Mental health and behavioural monitoring
- Harm minimisation strategies
- Treatment oversight and review
- Compliance and governance support
- Continuity of care pathways
Where appropriate, individuals may later transition back to their primary practitioner with improved treatment stability and clearer support structures in place.
How the Program Works
Referral or Self-Assessment
Individuals may enter the program through direct inquiry or referral from a clinic, practitioner, or healthcare provider.
Clinical & Behavioural Review
Our team conducts a structured assessment covering behavioural patterns, mental health history, treatment routines, lifestyle factors, and wellbeing goals.
Personalised Stabilisation Plan
Each individual receives a tailored support pathway designed to improve behavioural stability, treatment balance, and overall wellbeing.
Ongoing Monitoring & Support
Progress is supported through regular check-ins, behavioural guidance, education, and outcome tracking.
Continuity of Care
Where clinically appropriate, individuals may continue within the Hollograf ecosystem or transition back to their primary practitioner with updated support recommendations.
Integrated Mental Health & Behavioural Care
Hollograf is building one of Australia's first integrated behavioural support platforms focused on mental health, preventative care, and long-term treatment optimisation. Our long-term vision combines:
Patient stabilisation and behavioural support
Mental health monitoring and screening
Telehealth care pathways
AI-assisted patient monitoring and insights
Preventative mental health screening
Future integrative therapy models where legally appropriate
We believe the future of integrative healthcare depends on responsible, patient-focused care models that prioritise long-term outcomes, clinical integrity, and whole-person wellbeing.
Referrals & Partnerships
Hollograf welcomes referrals and partnership discussions with:
1
Integrative health clinics
2
Prescribing practitioners
3
Telehealth providers
4
Allied health professionals
5
Mental health practitioners
6
Healthcare organisations
To learn more about the Patient Support & Stabilisation Program, contact the Hollograf team today.
Get Involved With hollograf
Whether you are a clinician, researcher, investor, or patient — there is a place for you in the hollograf ecosystem.
Explore the Ecosystem
Learn more about our divisions, programs, and infrastructure.
Apply for Training
Join the hollograf Institute or International College of Psychedelics.
Partner With hollograf
Explore strategic, clinical, or research partnership opportunities.
Speak With Our Team
Connect directly with the hollograf leadership team.
hollograf — Building the future infrastructure of psychedelic medicine.
© 2026 hollograf. All Rights Reserved.